Experience

Davis Polk advised the underwriters on the registered offering of $425 million aggregate principal amount of 3.500% notes due 2029 and $575 million aggregate principal amount of 4.200%…

Davis Polk advised the initial purchasers in connection with a $350 million Regulation S high-yield offering by KWG Group Holding Limited of its 7.875% senior notes due 2023. KWG Group…

Davis Polk advised the joint book-running managers and underwriters on an SEC-registered offering by Stanley Black & Decker, Inc. of $500 million aggregate principal amount of 3…

Davis Polk advised the initial purchasers in connection with a $300 million Regulation S offering by CIFI Holdings (Group) Co. Ltd. of its 7.625% senior notes due 2023. Established in 2000…

Davis Polk advised Mitsubishi UFJ Lease & Finance Company Limited on its Rule 144A/Regulation S offering of senior notes, which consisted of $300 million aggregate principal amount of 3…

Davis Polk advised the underwriters in connection with a $644 million public offering of GoDaddy Inc. Class A common stock. Certain existing stockholders sold 8,538,616 shares and GoDaddy…

Davis Polk advised the joint lead managers on a Rule 144A/Regulation S offering by SP Group Treasury Pte. Ltd. of $600 million aggregate principal amount of 3.375% notes due 2029 under its…

Davis Polk advised CStone Pharmaceuticals in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…

Davis Polk advised the initial purchasers in connection with the Regulation S offering of $250 million 7.50% senior notes due 2021 by ENN Clean Energy International Investment Limited,…

Davis Polk is advising Roche on its approximately $4.3 billion acquisition of Spark Therapeutics, Inc. The transaction, which is expected to be completed in the second quarter of 2019, has…